Patent · US Active

Multimers, tetramers and octamers

US11453726B2 · kind B2 · utility

2Cited by
3References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 18, 2017
Grant dateSep 27, 2022
Priority date
Expiry dateDec 16, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/735
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The invention relates to multimers such as tetramers of polypeptides and tetramers and octamers of effector domains, such as antigen binding sites (eg, antibody or TCR binding sites that specifically bind to antigen or pMHC, or variable domains thereof) or peptides such as incretin, insulin or hormone peptides.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.